Atlas Trials

Hydroxychloroquine for COVID-19

Clinical trial NCT04342221 · TERMINATED

Trial details

NCT number
NCT04342221
Sponsor
University Hospital Tuebingen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19, Hydroxychloroquine Sulfate
Start date
2020-03-29
Primary completion
2021-02-26
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.